- Home
- NMG vs AQST Comparison
NMG vs AQST Comparison
Compare NMG & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- AQST
- Stock Information
- Founded
- NMG 2011
- AQST 2004
- Country
- NMG Canada
- AQST United States
- Employees
- NMG N/A
- AQST 135
- Industry
- NMG Other Metals and Minerals
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- NMG Basic Materials
- AQST Health Care
- Exchange
- NMG Nasdaq
- AQST Nasdaq
- Market Cap
- NMG 341.1M
- AQST 274.4M
- IPO Year
- NMG 2017
- AQST 2018
- Fundamental
- Price
- NMG $1.69
- AQST $3.01
- Analyst Decision
- NMG Strong Buy
- AQST Strong Buy
- Analyst Count
- NMG 1
- AQST 8
- Target Price
- NMG $3.00
- AQST $10.38
- AVG Volume (30 Days)
- NMG 80.9K
- AQST 2.0M
- Earning Date
- NMG 03-27-2025
- AQST 03-05-2025
- Dividend Yield
- NMG N/A
- AQST N/A
- EPS Growth
- NMG N/A
- AQST N/A
- EPS
- NMG N/A
- AQST N/A
- Revenue
- NMG N/A
- AQST $58,900,000.00
- Revenue This Year
- NMG N/A
- AQST $18.44
- Revenue Next Year
- NMG N/A
- AQST N/A
- P/E Ratio
- NMG N/A
- AQST N/A
- Revenue Growth
- NMG N/A
- AQST 22.56
- 52 Week Low
- NMG $1.22
- AQST $2.24
- 52 Week High
- NMG $2.82
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- NMG 38.52
- AQST 43.29
- Support Level
- NMG $1.78
- AQST $2.95
- Resistance Level
- NMG $2.07
- AQST $3.21
- Average True Range (ATR)
- NMG 0.13
- AQST 0.20
- MACD
- NMG -0.05
- AQST 0.02
- Stochastic Oscillator
- NMG 4.26
- AQST 18.42
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.